Cargando…
Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582836/ https://www.ncbi.nlm.nih.gov/pubmed/37603595 http://dx.doi.org/10.1182/bloodadvances.2023011203 |
| _version_ | 1785122422400221184 |
|---|---|
| author | Schubert, Maria-Luisa Bethge, Wolfgang A. Ayuk, Francis A. von Bonin, Malte Vucinic, Vladan Wagner-Drouet, Eva Marie Subklewe, Marion Baldus, Claudia D. Glass, Bertram Marks, Reinhard Mougiakakos, Dimitrios Schroers, Roland Stelljes, Matthias Topp, Max S. Wulf, Gerald Kröger, Nicolaus Dreger, Peter |
| author_facet | Schubert, Maria-Luisa Bethge, Wolfgang A. Ayuk, Francis A. von Bonin, Malte Vucinic, Vladan Wagner-Drouet, Eva Marie Subklewe, Marion Baldus, Claudia D. Glass, Bertram Marks, Reinhard Mougiakakos, Dimitrios Schroers, Roland Stelljes, Matthias Topp, Max S. Wulf, Gerald Kröger, Nicolaus Dreger, Peter |
| author_sort | Schubert, Maria-Luisa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10582836 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105828362023-10-19 Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study Schubert, Maria-Luisa Bethge, Wolfgang A. Ayuk, Francis A. von Bonin, Malte Vucinic, Vladan Wagner-Drouet, Eva Marie Subklewe, Marion Baldus, Claudia D. Glass, Bertram Marks, Reinhard Mougiakakos, Dimitrios Schroers, Roland Stelljes, Matthias Topp, Max S. Wulf, Gerald Kröger, Nicolaus Dreger, Peter Blood Adv Research Letter The American Society of Hematology 2023-08-23 /pmc/articles/PMC10582836/ /pubmed/37603595 http://dx.doi.org/10.1182/bloodadvances.2023011203 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Schubert, Maria-Luisa Bethge, Wolfgang A. Ayuk, Francis A. von Bonin, Malte Vucinic, Vladan Wagner-Drouet, Eva Marie Subklewe, Marion Baldus, Claudia D. Glass, Bertram Marks, Reinhard Mougiakakos, Dimitrios Schroers, Roland Stelljes, Matthias Topp, Max S. Wulf, Gerald Kröger, Nicolaus Dreger, Peter Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study |
| title | Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study |
| title_full | Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study |
| title_fullStr | Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study |
| title_full_unstemmed | Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study |
| title_short | Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study |
| title_sort | outcomes of axicabtagene ciloleucel in pmbcl compare favorably with those in dlbcl: a gla/drst registry study |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582836/ https://www.ncbi.nlm.nih.gov/pubmed/37603595 http://dx.doi.org/10.1182/bloodadvances.2023011203 |
| work_keys_str_mv | AT schubertmarialuisa outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT bethgewolfganga outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT ayukfrancisa outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT vonboninmalte outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT vucinicvladan outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT wagnerdrouetevamarie outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT subklewemarion outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT baldusclaudiad outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT glassbertram outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT marksreinhard outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT mougiakakosdimitrios outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT schroersroland outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT stelljesmatthias outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT toppmaxs outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT wulfgerald outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT krogernicolaus outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT dregerpeter outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy AT outcomesofaxicabtageneciloleucelinpmbclcomparefavorablywiththoseindlbclagladrstregistrystudy |